Lung Neoplasms — Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
Citation(s)
A Prospective, Multi-center, Single-arm Exploratory Clinical Study of Envafolimab Combined With Endostar in the First-line Treatment of Driver Gene-negative Advanced Non-small Cell Lung Cancer With PD-L1 Positive Expression